MedDataX Logo

Clinical Study Of Migraine Evolution

NCT ID: NCT00460005

Last Updated: 2008-04-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

250 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Understanding the speed at which migraine headaches develop is of importance to patients. Determining the proportions in which different headache pain build-up occurs, may provide health care practitioners with valuable information with which to prescribe the most appropriate treatment. Patients who experience a slow pain build-up may gain more benefit from medications which have a slow onset of effect, high tolerability and long action. Conversely, medications with a rapid onset of effect may be of greater benefit to patients who experience rapid onset of migraine pain.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Migraine Headache

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Migraine headache observational

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject is outpatient.
* Subject has a diagnosis of migraine with/without aura according to IHS criteria, of at least 1 years duration.
* Subject is able to comprehend the study procedures and to comply with study requirements.

Exclusion Criteria

* Subject has other chronic pain condition(s) not associated with migraine
* Subject is unable to understand the schedule/questionnaire.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

GlaxoSmithKline

INDUSTRY

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

GSK Clinical Trials, M.D.

Role: STUDY_DIRECTOR

GlaxoSmithKline

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

GSK Clinical Trials Call Centre

Calgary, Alberta, Canada

Site Status

GSK Clinical Trials Call Centre

Richmond, British Columbia, Canada

Site Status

GSK Clinical Trials Call Centre

Vancouver, British Columbia, Canada

Site Status

GSK Clinical Trials Call Centre

Saint John, New Brunswick, Canada

Site Status

GSK Clinical Trials Call Centre

Halifax, Nova Scotia, Canada

Site Status

GSK Clinical Trials Call Centre

Hamilton, Ontario, Canada

Site Status

GSK Clinical Trials Call Centre

Toronto, Ontario, Canada

Site Status

GSK Clinical Trials Call Centre

Unionville, Ontario, Canada

Site Status

GSK Clinical Trials Call Centre

Longueuil, Quebec, Canada

Site Status

GSK Clinical Trials Call Centre

Montreal, Quebec, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

S2W106188

Identifier Type: -

Identifier Source: org_study_id